Cumberland Pharmaceuticals Inc. Common Stock CPIX
i
Market dataready · fetched 2026-11-12T14:57:09.982Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-12T14:52:19.952967374Z
FundamentalsSEC EDGAR · ready · as of 2026-06-30 · fetched 2026-11-12T14:57:09.435984+00:00
Cumberland Pharmaceuticals Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 4.69 | 435.2% | 39.1% | |||
| 25Δ | 14.63 | 498.5% | 128.4% | 5.25 | 371.3% | 32.1% |
| 30Δ | 5.62 | 352.4% | 28.5% | |||
| 35Δ | 6.00 | 333.5% | 24.9% | |||
| 40Δ | 6.37 | 314.7% | 21.2% | |||
| 45Δ | 6.75 | 295.8% | 17.6% | |||
| 50Δ | 7.13 | 276.9% | 14.0% | |||
| 55Δ | 7.50 | 258.1% | 10.4% | |||
| 60Δ | 8.06 | 263.1% | 9.1% | |||
| 65Δ | 8.61 | 268.1% | 7.7% | |||
| 70Δ | 9.16 | 273.1% | 6.4% | |||
| 75Δ | 9.72 | 278.2% | 5.0% | |||
| 80Δ | ||||||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 4.69
- IV
- 435.2%
- B/E move
- 39.1%
25Δ
- Pseudo strike
- 14.63
- IV
- 498.5%
- B/E move
- 128.4%
- Pseudo strike
- 5.25
- IV
- 371.3%
- B/E move
- 32.1%
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 5.62
- IV
- 352.4%
- B/E move
- 28.5%
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 6.00
- IV
- 333.5%
- B/E move
- 24.9%
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 6.37
- IV
- 314.7%
- B/E move
- 21.2%
45Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 6.75
- IV
- 295.8%
- B/E move
- 17.6%
50Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 7.13
- IV
- 276.9%
- B/E move
- 14.0%
55Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 7.50
- IV
- 258.1%
- B/E move
- 10.4%
60Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 8.06
- IV
- 263.1%
- B/E move
- 9.1%
65Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 8.61
- IV
- 268.1%
- B/E move
- 7.7%
70Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 9.16
- IV
- 273.1%
- B/E move
- 6.4%
75Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 9.72
- IV
- 278.2%
- B/E move
- 5.0%
80Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 126.70% | |
| 132.59% | |
| 154.02% | |
| 137.49% | |
| 223.02% | |
| 184.74% | |
| 149.13% |
Drug Manufacturers - Specialty & Generic
CRDL
Cardiol Therapeutics Inc., a clinical-phase biotechnology company, focuses on the research and development of anti-inflammatory therapies for the treatment of cardiovascular…
More →CRON
Cronos Group Inc. is a cannabinoid company. The company is headquartered in Toronto, Canada.
More →DERM
Dermira, Inc., a biopharmaceutical company, develops and markets therapies for patients with dermatological diseases in the United States.
More →EBS
Description unavailable
More →ELAN
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures and markets products for pets and farm animals. The company is headquartered in…
More →EOLS
Description unavailable
More →